Next 10 |
2024-04-18 16:54:40 ET More on DermTech DermTech, Inc. (DMTK) Q4 2023 Earnings Call Transcript DermTech GAAP EPS of -$0.56 in-line, revenue of $3.92M misses by $0.11M DermTech Q4 2023 Earnings Preview Seeking Alpha’s Quant Rating on DermTech Hi...
DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced the presentation of two research abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting, taking place March 8th-12th i...
A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 44.2% to $0.0851 on volume of 271,253,038 shares Fisker Inc. Class A (FSR) fell 27.2% to $0.53 on volume of 253,915,529 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 12.5% to $3.325 on v...
Evolv Technologies Holdings Inc. (EVLV) is expected to report $-0.14 for Q4 2023 The Lion Electric Company (LEV) is expected to report $-0.1 for Q4 2023 Fisker Inc. Class A (FSR) is expected to report $-0.2 for Q4 2023 Y-mAbs Therapeutics Inc. (YMAB) is expected to report $-0.19 for Q...
DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, will host a conference call and webcast on Thursday, February 29, 2024 at 5:00 p.m. Eastern Time (ET) to discuss the Company's fourth-quarter 2023 operati...
2024-01-31 17:32:28 ET More on DermTech DermTech, Inc. (DMTK) Q3 2023 Earnings Call Transcript DermTech study finds melanoma test effective for all skin types DermTech stock rallies 18% on positive study for melanoma test Seeking Alpha’s Quant Rating o...
- Ongoing emphasis on growing revenue for the DermTech Melanoma Test (DMT) - Approximately $40 million in total operating expense reductions compared to fiscal 2022 resulting from all restructuring actions DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in pr...
2024-01-18 15:04:11 ET More on DermTech DermTech, Inc. (DMTK) Q3 2023 Earnings Call Transcript DermTech stock rallies 18% on positive study for melanoma test DermTech Q3 2023 Earnings Preview Seeking Alpha’s Quant Rating on DermTech Historical ...
- Study demonstrated the DMT’s effectiveness as a melanoma rule-out test for all skin types - Negative predictive value (NPV) higher than 99% regardless of skin type DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a ...
- Trust 2 Study confirms negative predictive value (NPV) of 99.7% for the foundational gene expression assay - Optional TERT promoter mutation testing does not significantly alter sensitivity, NPV or positive predictive value (PPV) DermTech, Inc. (NASDAQ: DMTK) (DermTech or th...
News, Short Squeeze, Breakout and More Instantly...
DermTech Inc Company Name:
DMTK Stock Symbol:
NYSE Market:
DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced the presentation of two research abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting, taking place March 8th-12th i...
Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results. Zscaler posted better-tha...
A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 44.2% to $0.0851 on volume of 271,253,038 shares Fisker Inc. Class A (FSR) fell 27.2% to $0.53 on volume of 253,915,529 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 12.5% to $3.325 on v...